L & S Advisors Inc Eli Lilly & CO Transaction History

L & S Advisors Inc

$832 Million
Q3 2024

A detailed history of L & S Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, L & S Advisors Inc holds 16,477 shares of LLY stock, worth $13.1 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

16,477

Previous 19,116 13.81%

Holding current value

$13.1 Million

Previous $17.3 Million 15.66%

% of portfolio

1.75%

Previous 2.25%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $2.04 Million - $2.53 Million	-2,639 Reduced 13.81%	16,477 $14.6 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $677,028 - $849,043	934 Added 5.14%	19,116 $17.3 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $1.56 Million - $2.08 Million	-2,631 Reduced 12.64%	18,182 $14.1 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $7.65 Million - $9.02 Million	-14,572 Reduced 41.18%	20,813 $12.1 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $4.03 Million - $5.56 Million	9,270 Added 35.5%	35,385 $19 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $595,556 - $796,328	-1,698 Reduced 6.11%	26,115 $12.2 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $2.6 Million - $3.05 Million	-8,371 Reduced 23.13%	27,813 $9.55 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $3.17 Million - $3.7 Million	-9,871 Reduced 21.43%	36,184 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.36 Million - $2.69 Million	7,957 Added 20.89%	46,055 $14.9 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $5.52 Million - $6.48 Million	19,812 Added 108.35%	38,098 $12.4 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $1.61 Million - $2 Million	6,868 Added 60.15%	18,286 $5.24 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $2.57 Million - $3.19 Million	11,418 New	11,418 $3.15 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $5.11 Million - $5.96 Million	-46,090 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $1.46 Million - $1.72 Million	13,149 Added 39.92%	46,090 $5.98 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $3.49 Million - $3.91 Million	32,941 New	32,941 $3.81 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $2.33 Million - $2.75 Million	-31,444 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $58,177 - $62,401	-710 Reduced 2.21%	31,444 $2.66 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.48 Million - $2.75 Million	32,154	32,154 $2.75 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account